학술논문
Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)
Document Type
Article
Author
Source
In ESMO Open May 2024 9(5)
Subject
Language
ISSN
2059-7029